3-[3-[4-(2-isocyanatoethyl)phenyl]phenyl]-5-piperidin-4-yl-1,2,4-oxadiazole
C22H22N4O2 — CID 155066742
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[3-[4-(2-isocyanatoethyl)phenyl]phenyl]-5-piperidin-4-yl-1,2,4-oxadiazole
3-[3-[4-(2-isocyanatoethyl)phenyl]phenyl]-5-piperidin-4-yl-1,2,4-oxadiazole (PubChem CID 155066742) has the molecular formula C22H22N4O2 and a molecular weight of 374.44 g/mol. Its IUPAC name is 3-[3-[4-(2-isocyanatoethyl)phenyl]phenyl]-5-piperidin-4-yl-1,2,4-oxadiazole.
Molecular Properties
| Compound Name | 3-[3-[4-(2-isocyanatoethyl)phenyl]phenyl]-5-piperidin-4-yl-1,2,4-oxadiazole |
|---|---|
| PubChem CID | 155066742 |
| Molecular Formula | C22H22N4O2 |
| Molecular Weight | 374.44 g/mol |
| Exact Mass | 374.17 |
| IUPAC Name | 3-[3-[4-(2-isocyanatoethyl)phenyl]phenyl]-5-piperidin-4-yl-1,2,4-oxadiazole |
| SMILES | O=C=NCCc1ccc(-c2cccc(-c3noc(C4CCNCC4)n3)c2)cc1 |
| InChI | InChI=1S/C22H22N4O2/c27-15-24-11-8-16-4-6-17(7-5-16)19-2-1-3-20(14-19)21-25-22(28-26-21)18-9-12-23-13-10-18/h1-7,14,18,23H,8-13H2 |
| InChIKey | UNVNMYNVHURXCO-UHFFFAOYSA-N |
| XLogP | 3.75 |
| TPSA | 80.38 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 374.44 |
| LogP ≤ 5 | 3.75 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'isocyanate', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155066742 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.